SHARON GANT: Open Payments
NPI 1487362349 · ARLINGTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 17 payments from 7 companies in 2025. Trend: 2023 $285 · 2024 $235 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $104 |
| Novo Nordisk Inc | 3 | $81 |
| Lilly USA, LLC | 3 | $56 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| Antares Pharma, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $24 |
| Dexcom, Inc. | 1 | $14 |
Products named: OTEZLA, Ozempic, MOUNJARO, GVOKE HYPOPEN, XYOSTED, PAXLOVID, Dexcom G6 Transmitter.
Industry payments across TN — which companies pay providers there.
